VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,425,014 | +113.0% | 312,905 | +214.7% | 0.00% | +100.0% |
| Q2 2023 | $1,138,588 | +40.9% | 99,440 | +12.6% | 0.00% | 0.0% |
| Q1 2020 | $808,000 | -34.0% | 88,314 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $1,224,000 | -54.5% | 87,756 | -43.8% | 0.00% | -66.7% |
| Q3 2019 | $2,689,000 | -24.7% | 156,234 | +19.1% | 0.00% | -25.0% |
| Q2 2019 | $3,569,000 | -2.7% | 131,131 | -31.6% | 0.00% | 0.0% |
| Q1 2019 | $3,668,000 | +1460.9% | 191,663 | +667.4% | 0.00% | – |
| Q4 2018 | $235,000 | – | 24,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |